Imprimir Ver referencias Citación AMA Citation Chan A, Shah R. Chan A, Shah R Chan, Alex, and Ravi Shah. "Fish oil supplementation likely reduces cardiovascular morbidity and mortality." 2 Minute Medicine, 25 marzo 2020. McGraw-Hill, New York, NY, 2020. AccessMedicina. http://accessmedicina.mhmedical.com/updatesContent.aspx?gbosid=541694§ionid=242856492 MLA Citation Chan A, Shah R. Chan A, Shah R Chan, Alex, and Ravi Shah.. "Fish oil supplementation likely reduces cardiovascular morbidity and mortality." 2 Minute Medicine New York, NY: McGraw-Hill, 2020, http://accessmedicina.mhmedical.com/updatesContent.aspx?gbosid=541694§ionid=242856492. Descargar archivo de la citación: RIS (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley © Copyright Clip Capítulo completo Sólo figuras Sólo cuadros Solo Videos Supplementary Content Arriba Fish oil supplementation likely reduces cardiovascular morbidity and mortality by Alex Chan, Ravi Shah Listen +Originally published by 2 Minute Medicine® (view original article). Reused on AccessMedicine with permission. +1. Regular consumption of fish oil is likely associated with decreased all-cause and cardiovascular disease risk. +2. Consumption of fish oil was associated with decreased incidence of cardiovascular events with effects being most pronounced in patients with hypertension. +Evidence Rating: 2 (Good) +Lifestyle modification and dietary supplementation have long been recognized as potential avenues of additional therapeutic options to manage and prevent cardiovascular disease (CVD). Fish oil and omega 3 fatty acid supplementation have previously been recognized as products that could potentially prevent CVD and have widespread usage globally despite follow-up investigations providing inconclusive results. To better characterize its suitability for usage in the general population, researchers conducted a large-scale cohort study consisting of 427,678 participants aged 40 to 69 in the UK investigating the associations between fish oil supplementation with all-cause mortality, CVD mortality, and CVD events, consisting of strokes and myocardial infarction. Median follow up times were 9 years for mortality outcomes and 8.1 years for CVD events. Compared to controls, the cohort of 133,438 participants self-reporting habitual use of fish oil supplements had lower hazard ratios for all-cause mortality (0.87; 95% CI 0.83 – 0.90), CVD mortality (0.84; 95% CI, 0.78 – 0.91), and CVD events (0.93; 95% CI, 0.90 – 0.96). The effect of CVD event mitigation was most pronounced with patients with hypertension. Results were independent of possible confounding risk factors such as sex, BMI, physical activity, and diet. Findings from the study provide further evidence to suggest a role for fish oil supplementation in providing a marginal benefit for CVD management and the prevention of mortality from all causes and CVD. +Click to read the study in BMJ +©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.